Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent [12]

Journal of the American Geriatrics Society

Volumn 56, Issue 2, 2008, Pages 371-373

  Trifirò, Gianluca ^a   Morgante, Letterio ^b   Tari, Michele ^c   Arcoraci, Vincenzo ^a   Savica, Rodolfo ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Caserta 1 Local Health Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT ALKALOID; LISURIDE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SEROTONIN 2B RECEPTOR;

CARDIOVASCULAR DISEASE; DATA BASE; ELDERLY CARE; GENERAL PRACTICE; HEART MUSCLE FIBROSIS; HUMAN; LETTER; MEDICAL SPECIALIST; MYOFIBROBLAST; OUTPATIENT CARE; PARKINSON DISEASE; PRESCRIPTION; PROTEIN EXPRESSION; VALVULAR HEART DISEASE;

AGED; ANTIPARKINSON AGENTS; CARDIOVASCULAR DISEASES; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; MALE; PARKINSON DISEASE; PERGOLIDE; TREATMENT OUTCOME;

EID: 38549093492     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01522.x     Document Type: Letter

References (7)

1. Flowers CM, Racoosin JA, Lu SI et al. The US Food and Drug Administration's registry of patients with pergolide associated valvular heart disease. Mayo Clin Proc 2003 78 : 730 731.
2. Schade R, Andersohn F, Suissa S et al. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007 356 : 29 38.
3. Zanettini R, Antonini A, Gatto G et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007 356 : 39 46.
4. Rothman RB, Baumann MH, Savage JE et al. Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 2000 102 : 2836 2841.
5. Millan MJ, Maiofiss L, Cussac D et al. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 2002 303 : 791 804.
6. Koller WC. Treatment of early Parkinson's disease. Neurology 2002 58 (4 Suppl 1) : S79 S86.
7. Tendera M. The epidemiology of heart failure. J Renin Angiotensin Aldosterone Syst 2004 5 (Suppl 1) : S2 S6.